falsefalse

ASCO 2024: Updates in the Treatment of Advanced Renal Cell Carcinoma - Episode 13

Select Ongoing Trials for nccRCC and Impact on the Treatment Landscape

, , ,

Video Player is loading.
Current Time 0:00
Duration 2:31
Loaded: 0.00%
Stream Type LIVE
Remaining Time 2:31
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
  • en (Main), selected
  1. Please review ongoing trials for patients with nccRCC and discuss the potential impact of these studies on the treatment landscape.
  2. Phase 2 KEYNOTE-B61 trial, comparing len + pembro in 1L nccRCC 
  3. Please provide a brief background surrounding KEYNOTE-B61
  4. Please discuss extended follow-up presented at ASCO GU 2024
  5. Phase 2 trial assessing nivo + cabo (
x